Audion Therapeutics Overview

  • Founded
  • 2008

Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $2.81M

  • Investors
  • 3

Audion Therapeutics General Information

Description

Operator of a clinical-stage company intended to develop therapies to treat hearing loss. The company is involved in the discovery of disease-intervention therapies through an approach of restoring the function of hearing by targeting a protein complex called gamma-secretase, enabling medical professionals to address sensorineural hearing loss (SNHL), due to aging more efficiently.

Contact Information

Website
www.audiontherapeutics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Primary Office
  • Hogeweg 54
  • 1098 CE Amsterdam
  • Netherlands
+31 06 00000000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Audion Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series A) 24-Sep-2015 $2.81M 00.000 Completed Generating Revenue
2. Grant 08-Sep-2015 00.000 Completed Generating Revenue
1. Later Stage VC 10-Feb-2014 Completed Generating Revenue
To view Audion Therapeutics’s complete valuation and funding history, request access »

Audion Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a clinical-stage company intended to develop therapies to treat hearing loss. The company is involved in the
Drug Discovery
Amsterdam, Netherlands
00.000
00000000000 00.000

000000

labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitati
0000 000000000
Boston, MA
00 As of 0000
00000
0000 0000-00-00
000000&0 00000

000000

ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit
0000 000000000
Seattle, WA
0 As of 0000
00000
0000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Audion Therapeutics Competitors (14)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Akouos Formerly VC-backed Boston, MA 00 00000 000000&0 00000
0000000 0000000000 Accelerator/Incubator Backed Seattle, WA 0 00000 0000000000
0000000 0000000000 Formerly VC-backed Boston, MA 00 00000 000000&0 00000
000000000 000000 Venture Capital-Backed Burlington, MA 00 00000 00000000000 00000
000000000 00000000 Formerly VC-backed Lexington, MA 00 00000 000000&0 00000
You’re viewing 5 of 14 competitors. Get the full list »

Audion Therapeutics Executive Team (5)

Name Title Board Seat Contact Info
Rolf Jan Rutten Chief Executive Officer
Helmuth Van Es Ph.D Co-Founder & Chief Scientific Officer
Albert Edge Ph.D Co-Founder & Consultant
Peter Weber MD Chief Medical Officer
You’re viewing 4 of 5 executive team members. Get the full list »

Audion Therapeutics Board Members (2)

Name Representing Role Since
Thijs Cohen Tervaert MD Self Board Member 000 0000
You’re viewing 1 of 2 board members. Get the full list »

Audion Therapeutics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Inkef Venture Capital Minority 000 0000 000000 0
Horizon 2020 SME Instrument Government 000 0000 000000 0
Eli Lilly Corporation Minority 000 0000 000000 0
To view Audion Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial